SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-160358
Filing Date
2023-06-05
Accepted
2023-06-05 08:37:00
Documents
14
Period of Report
2023-06-05
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d453826d8k.htm   iXBRL 8-K 27923
2 EX-99.1 d453826dex991.htm EX-99.1 22101
6 GRAPHIC g453826g0605060251379.jpg GRAPHIC 3404
  Complete submission text file 0001193125-23-160358.txt   185545

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nexi-20230605.xsd EX-101.SCH 2825
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nexi-20230605_lab.xml EX-101.LAB 17977
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nexi-20230605_pre.xml EX-101.PRE 11241
8 EXTRACTED XBRL INSTANCE DOCUMENT d453826d8k_htm.xml XML 3340
Mailing Address 9119 GAITHER ROAD GAITHERSBURG MD 20878
Business Address 9119 GAITHER ROAD GAITHERSBURG MD 20878 301-825-9810
NexImmune, Inc. (Filer) CIK: 0001538210 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40045 | Film No.: 23991336
SIC: 2834 Pharmaceutical Preparations